Research / BLKB / Fundamental state Inspectable configuration
State dimensions Filing 0001280058-17-000019 General Corporate
Debt relative to revenue 56th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.debt_to_revenue
194.08% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.48% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
6.95% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
8.49% · CORE · NOT_ENOUGH_HISTORY
Gross margin 67th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
53.45% · CORE · VALID
Operating margin 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
5.76% · CORE · VALID
R&D intensity 22th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
12.37% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
5.06% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 47 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 47.05%
Current 194.08%
Delta 147.03% Capex Intensity Decreased
Previous 2.42%
Current 1.48%
Delta -0.94% Cash Generation Decreased
Previous 21.02%
Current 6.95%
Delta -14.07% Growth Decreased
Previous 14.56%
Current 8.49%
Delta -6.07% Margin Decreased
Previous 53.58%
Current 53.45%
Delta -0.14% Profitability Decreased
Previous 8.46%
Current 5.76%
Delta -2.69% R And D Intensity Increased
Previous 12.30%
Current 12.37%
Delta 0.07% Sbc Intensity Increased
Previous 4.47%
Current 5.06%
Delta 0.60% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.